주요 외국의 희귀의약품과 항암제 별도 기금 제도 고찰 및 시사점

• 영문명: The Review of Orphan or Anticancer Drugs Funding Programs from Foreign Countries Experiences
• 발행기관: 대한약학회
• 저자명: 정승연(Seungyeon Jung) 김수진(Sujin Kim) 김동숙(Dong-Sook Kim)
• 간행물 정보: 『약학회지』제61권 제2호(2017년), 100~108쪽, 전체 9쪽
• 주제분류: 의약학 > 기타의약학
• 파일형태: PDF
• 발행일자: 2017.04.30

영문 초록

The purpose of this study was to review foreign orphan or anticancer funding programs and to suggest an applicable policy development plan in the Korean domestic situation. We conducted web searches and literature review on pharmaceutical funding programs in several countries including Australia, Belgium, Canada, Italy, New Zealand, and the United Kingdom. Funding programs were studied in terms of managing agents, target medicines, beneficiaries, and sources of funding. We found out that most programs are financially dependent on their own countries and there are more programs for orphan drugs than for anticancer drugs across countries. Based on the review of foreign funding programs, we suggest that developing practical pharmaceutical funding programs may help patients to access anticancer and orphan drugs.

목차

연구방법

연구결과

고 찰

결 론

키워드

medicines fund orphan drugs anticancer drugs foreign countries access to medicines